Search Results - "VILARDELL, M."

Refine Results
  1. 1

    Cold spray as an emerging technology for biocompatible and antibacterial coatings: state of art by Vilardell, A. M., Cinca, N., Concustell, A., Dosta, S., Cano, I. G., Guilemany, J. M.

    Published in Journal of materials science (01-07-2015)
    “…The use of coatings in biomaterials has been fundamental on the applicability of many medical devices and has helped improve mechanical properties such as wear…”
    Get full text
    Journal Article
  2. 2
  3. 3

    DUSP23 is over‐expressed and linked to the expression of DNMTs in CD4+ T cells from systemic lupus erythematosus patients by Balada, E., Felip, L., Ordi‐Ros, J., Vilardell‐Tarrés, M.

    Published in Clinical and experimental immunology (01-02-2017)
    “…Summary We evaluated the transcriptional expression of dual‐specificity protein phosphatase 23 (DUSP23) in CD4+ T cells from 30 systemic lupus erythematosus…”
    Get full text
    Journal Article
  4. 4

    Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial by Cobo, E, Cortés, J, Ribera, J M, Cardellach, F, Selva-O’Callaghan, A, Kostov, B, García, L, Cirugeda, L, Altman, D G, González, J A, Sànchez, J A, Miras, F, Urrutia, A, Fonollosa, V, Rey-Joly, C, Vilardell, M

    Published in BMJ (22-11-2011)
    “…Objective To investigate the effect of an additional review based on reporting guidelines such as STROBE and CONSORT on quality of manuscripts.Design Masked…”
    Get full text
    Journal Article
  5. 5

    Cause-specific mortality after a breast cancer diagnosis: a cohort study of 10,195 women in Girona and Tarragona by Ameijide, A., Clèries, R., Carulla, M., Buxó, M., Marcos-Gragera, R., Martínez, J. M., Vilardell, M. L., Vilardell, M., Espinàs, J. A., Borràs, J. M., Izquierdo, Á., Galceran, J.

    Published in Clinical & translational oncology (01-08-2019)
    “…Introduction Evidence suggests an excess of long-term mortality due to cardiovascular diseases, second tumours and other causes in patients diagnosed with…”
    Get full text
    Journal Article
  6. 6

    A New Alternative for Obtaining Nanocrystalline Bioactive Coatings: Study of Hydroxyapatite Deposition Mechanisms by Cold Gas Spraying by Cinca, Núria, Vilardell, Anna M., Dosta, Sergi, Concustell, Amadeu, Garcia Cano, Irene, Guilemany, Josep Maria, Estradé, Sonia, Ruiz, Alicia, Peiró, Francesca

    Published in Journal of the American Ceramic Society (01-04-2016)
    “…The present article is intended to study the deposition mechanisms of bioactive hydroxyapatite (HA) particles by means of Cold Gas Spraying (CGS). A comparison…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Feasibility of using low pressure cold gas spray for the spraying of thick ceramic hydroxyapatite coatings by Vilardell, Anna M., Cinca, Núria, Dosta, Sergi, Cano, Irene G., Guilemany, Josep M.

    “…This article deals with the production of thick ceramic hydroxyapatite coatings obtained by Low Pressure Cold Gas Spray (LPCGS) system. Several factors such as…”
    Get full text
    Journal Article
  9. 9

    Autoimmune/inflammatory syndrome (ASIA) induced by biomaterials injection other than silicone medical grade by Alijotas-Reig, J, Garcia-Gimenez, V, Llurba, E, Vilardell-Tarrés, M

    Published in Lupus (01-10-2012)
    “…Background: Systemic autoimmune/granulomatous adverse reactions related to biomaterials other than silicone have rarely been reported. Aim: The aim of this…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Predicting the cancer burden in Catalonia between 2015 and 2025: the challenge of cancer management in the elderly by Clèries, R., Ameijide, A., Marcos-Gragera, R., Pareja, L., Carulla, M., Vilardell, M.-L., Esteban, L., Buxó, M., Espinàs, J.-A., Puigdefàbregas, A., Ribes, J., Izquierdo, A., Galceran, J., Borrás, J. M.

    Published in Clinical & translational oncology (01-05-2018)
    “…Background Developing effective cancer control programmes requires information on the future cancer burden in an ageing population. In our study we predicted…”
    Get full text
    Journal Article
  14. 14

    Flexible manufacturing of functional ceramic coatings by inkjet printing by Vilardell, M., Granados, X., Ricart, S., Van Driessche, I., Palau, A., Puig, T., Obradors, X.

    Published in Thin solid films (02-12-2013)
    “…The implementation of chemical solution deposition methodology with drop on demand inkjet printing technology demonstrates being a highly flexible and low-cost…”
    Get full text
    Journal Article
  15. 15

    Thalidomide in the treatment of refractory cutaneous lupus erythematosus: prognostic factors of clinical outcome by Cortés-Hernández, J., Torres-Salido, M., Castro-Marrero, J., Vilardell-Tarres, M., Ordi-Ros, J.

    Published in British journal of dermatology (1951) (01-03-2012)
    “…Summary Background  Although thalidomide has been shown to be effective in patients with refractory cutaneous lupus erythematosus (CLE), its use is still…”
    Get full text
    Journal Article
  16. 16

    Assessing predicted age-specific breast cancer mortality rates in 27 European countries by 2020 by Clèries, R., Rooney, R. M., Vilardell, M., Espinàs, J. A., Dyba, T., Borras, J. M.

    Published in Clinical & translational oncology (01-03-2018)
    “…Background We assessed differences in predicted breast cancer (BC) mortality rates, across Europe, by 2020, taking into account changes in the time trends of…”
    Get full text
    Journal Article
  17. 17

    Fracture mechanisms in the as-built and stress-relieved laser powder bed fusion Ti6Al4V ELI alloy by Vilardell, A.M., Fredriksson, G., Yadroitsev, I., Krakhmalev, P.

    Published in Optics and laser technology (01-01-2019)
    “…•As-built LPBF Ti6Al4V ELI specimens have a fully martensitic microstructure.•Stress-relief leads to a coarsening of needles and precipitations. No β-phase was…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Churg–Strauss syndrome: outcome and long‐term follow‐up of 32 patients by Solans, R., Bosch, J. A., Pérez‐Bocanegra, C., Selva, A., Huguet, P., Alijotas, J., Orriols, R., Armadans, L., Vilardell, M.

    Published in Rheumatology (Oxford, England) (01-07-2001)
    “…Objectives. To study the clinical spectrum and evolution of Churg–Strauss syndrome in order to assess the clinicopathological features of the disease, the…”
    Get full text
    Journal Article
  20. 20

    Clinical features and therapeutic management of subglottic stenosis in patients with Wegener’s granulomatosis by Solans-Laqué, R, Bosch-Gil, JA, Canela, M, Lorente, J, Pallisa, E, Vilardell-Tarrés, M

    Published in Lupus (01-09-2008)
    “…The objective of the study was to evaluate the clinical features, response to treatment, and long-term outcome of subglottic stenosis (SGS) in a series of…”
    Get full text
    Journal Article